Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Werewolf Therapeutics, Inc. (HOWL) had Weighted-Average Shares Outstanding (Diluted) of 49.39M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-13.53M |
|
-- |
|
-- |
|
$13.27M |
|
$-13.27M |
|
$-0.26M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.53M |
|
$-13.27M |
|
$-12.87M |
|
48.60M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
49.39M |
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$48.73M |
|
$4.29M |
|
$9.29M |
|
$58.02M |
|
$38.52M |
|
-- |
|
$7.30M |
|
$45.82M |
|
$12.20M |
|
$12.20M |
|
$12.20M |
|
48.60M |
|
| Cash Flow Statement Financials | |
$-10.60M |
|
-- |
|
-- |
|
$57.95M |
|
$47.35M |
|
$-10.60M |
|
$0.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.27 |
|
-- |
|
-- |
|
-- |
|
2.36 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-10.60M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-110.90% |
|
-110.90% |
|
-23.32% |
|
-110.90% |
|
$0.25 |
|
$-0.21 |
|
$-0.21 |
|